ZA973885B - Cationic virosomes as transfer system for genetic material - Google Patents

Cationic virosomes as transfer system for genetic material

Info

Publication number
ZA973885B
ZA973885B ZA973885A ZA973885A ZA973885B ZA 973885 B ZA973885 B ZA 973885B ZA 973885 A ZA973885 A ZA 973885A ZA 973885 A ZA973885 A ZA 973885A ZA 973885 B ZA973885 B ZA 973885B
Authority
ZA
South Africa
Prior art keywords
transfer system
genetic material
cationic virosomes
virosomes
cationic
Prior art date
Application number
ZA973885A
Other languages
English (en)
Inventor
Peter Klein
Reinhard Gluck
Ernst Rudolf Walti
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of ZA973885B publication Critical patent/ZA973885B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA973885A 1996-05-08 1997-05-06 Cationic virosomes as transfer system for genetic material ZA973885B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96107282 1996-05-08

Publications (1)

Publication Number Publication Date
ZA973885B true ZA973885B (en) 1998-11-06

Family

ID=8222763

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA973885A ZA973885B (en) 1996-05-08 1997-05-06 Cationic virosomes as transfer system for genetic material

Country Status (28)

Country Link
US (1) US6210708B1 (ja)
EP (1) EP0902682A2 (ja)
JP (1) JP2000509404A (ja)
KR (1) KR100536983B1 (ja)
CN (1) CN1271992C (ja)
AR (1) AR007054A1 (ja)
AU (1) AU710170B2 (ja)
BG (1) BG102880A (ja)
BR (1) BR9709224A (ja)
CA (1) CA2253561A1 (ja)
CO (1) CO4600638A1 (ja)
CZ (1) CZ299809B6 (ja)
EA (1) EA003130B1 (ja)
GT (1) GT199700058A (ja)
HR (1) HRP970234B1 (ja)
HU (1) HUP9901790A3 (ja)
ID (1) ID17934A (ja)
NO (1) NO327726B1 (ja)
NZ (1) NZ332666A (ja)
OA (1) OA10916A (ja)
PA (1) PA8429201A1 (ja)
PE (1) PE65198A1 (ja)
PL (1) PL199201B1 (ja)
SK (1) SK152698A3 (ja)
SV (1) SV1997000032A (ja)
TN (1) TNSN97080A1 (ja)
WO (1) WO1997041834A1 (ja)
ZA (1) ZA973885B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113347A1 (en) * 1991-05-08 2003-06-19 Schweiz. Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
WO1999012575A1 (en) * 1997-09-08 1999-03-18 Promega Corporation Method of in vivo transformation utilizing lipid vehicles
SE513149C2 (sv) * 1997-12-05 2000-07-17 Katarina Edwards Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna
TR200200930T2 (tr) * 1999-10-08 2002-08-21 Nika Health Products Limited Katyonik dosper virosomlar
WO2001044023A1 (de) * 1999-12-17 2001-06-21 Duerschinger Guenter Induktiv aktivierbare zündkapsel für insassen-rückhaltesysteme und prüfschaltung für diese zündkapsel
US20030139361A1 (en) * 2000-01-21 2003-07-24 Kazuhiro Yuda Drug for gene therapy
CA2449013C (en) * 2001-07-23 2012-05-22 Onyx Pharmaceuticals, Inc. Viral mutants that selectively replicate in targeted human cancer cells
KR100411234B1 (ko) * 2001-08-14 2003-12-18 한국과학기술원 올리고뉴클레오티드 혼성화 미셀 및 그의 제조방법
WO2003038103A1 (en) * 2001-10-29 2003-05-08 Atso Raasmaja Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
US20040028687A1 (en) * 2002-01-15 2004-02-12 Waelti Ernst Rudolf Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
US20040176283A1 (en) * 2002-04-01 2004-09-09 Robinson John A. Methods and compositions for the design of synthetic vaccines
BR0316402A (pt) * 2002-11-21 2006-02-21 Pevion Biotech Ltd vesìcula fusogênica, métodos para preparar uma vesìcula fusogênica encapsulante, e para encapsular pelo menos uma substáncia terapêutica ou imunologicamente ativa em uma vesìcula fusogênica, uso de uma vesìcula fusogênica, e, formulação farmacêutica
US8039587B2 (en) 2003-10-24 2011-10-18 Gencia Corporation Methods and compositions for delivering polynucleotides
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US20090208478A1 (en) * 2003-10-24 2009-08-20 Gencia Corporation Transducible polypeptides for modifying metabolism
DE102004057303A1 (de) * 2004-11-26 2006-06-01 Merck Patent Gmbh Stabile Kristallmodifikationen von DOTAP Chlorid
US20070172520A1 (en) * 2005-11-18 2007-07-26 University Of South Florida Immunotargeting of Nonionic Surfactant Vesicles
EP2064229B1 (en) 2006-09-15 2015-08-12 Ottawa Hospital Research Institute Oncolytic rhabdovirus
KR101242113B1 (ko) * 2010-10-22 2013-03-19 고마바이오텍(주) 유전자 전달용 양이온성 센다이 ｆ／ｈｎ 바이로좀 복합체
WO2013032643A2 (en) * 2011-08-31 2013-03-07 Dicerna Pharmaceuticals, Inc. Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells
EP2763696B1 (en) * 2011-10-07 2018-09-19 iSD Immunotech ApS Identification of the immunosuppressive domains in fusion proteins of enveloped rna viruses
US11241476B2 (en) 2016-09-27 2022-02-08 Camurus Ab Mixtures and formulations comprising an alkyl ammonium EDTA salt
CN109055432B (zh) * 2018-08-16 2020-10-13 南京科佰生物科技有限公司 慢病毒感染试剂及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
ES2135406T3 (es) * 1991-05-08 1999-11-01 Schweiz Serum & Impfinst Virosomas de la influenza reconstituidos inmunoestimulantes e inmunopotencializadores y vacunas que los contienen.
AU3614493A (en) 1992-02-04 1993-09-01 Chiron Corporation Non-toxic lipid vaccine formulations
US5631237A (en) 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
WO1995002698A1 (en) * 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
AU2520595A (en) * 1994-05-31 1995-12-21 Inex Pharmaceuticals Corp. Virosome-mediated intracellular delivery of therapeutic agents
FR2726764B1 (fr) 1994-11-14 1997-01-31 Pasteur Merieux Serums Vacc Adjuvant pour composition vaccinale

Also Published As

Publication number Publication date
NO985137D0 (no) 1998-11-04
GT199700058A (es) 1998-10-29
AR007054A1 (es) 1999-10-13
JP2000509404A (ja) 2000-07-25
CZ361498A3 (cs) 1999-03-17
NO985137L (no) 1999-01-04
KR20000010780A (ko) 2000-02-25
AU2776697A (en) 1997-11-26
PL329853A1 (en) 1999-04-12
NZ332666A (en) 2000-05-26
TNSN97080A1 (fr) 2005-03-15
CA2253561A1 (en) 1997-11-13
HUP9901790A2 (hu) 1999-08-30
US6210708B1 (en) 2001-04-03
SV1997000032A (es) 1998-03-27
OA10916A (en) 2003-02-21
KR100536983B1 (ko) 2006-06-29
BG102880A (en) 1999-05-31
PE65198A1 (es) 1998-10-16
CN1225007A (zh) 1999-08-04
HRP970234B1 (en) 2002-04-30
NO327726B1 (no) 2009-09-14
BR9709224A (pt) 1999-08-10
HUP9901790A3 (en) 2010-11-29
PA8429201A1 (es) 2000-05-24
AU710170B2 (en) 1999-09-16
EP0902682A2 (en) 1999-03-24
CZ299809B6 (cs) 2008-12-03
EA003130B1 (ru) 2003-02-27
HRP970234A2 (en) 1998-06-30
ID17934A (id) 1998-02-12
EA199800992A1 (ru) 1999-06-24
CO4600638A1 (es) 1998-05-08
CN1271992C (zh) 2006-08-30
PL199201B1 (pl) 2008-08-29
WO1997041834A1 (en) 1997-11-13
SK152698A3 (en) 1999-05-07

Similar Documents

Publication Publication Date Title
ZA973885B (en) Cationic virosomes as transfer system for genetic material
GB2322438B (en) Feed system
AU1830200A (en) Cationic liposomes for gene transfer
IL127416A0 (en) Method for enhancing gene transfer
CZ20001713A3 (cs) Způsob výroby citalopramu
EP0997530A4 (en) DNA POLYMERASE RELATED FACTORS
ZA988434B (en) New plant genes
IL134059A0 (en) Process for preparing aminoarylacetylenes
EG23935A (en) Process for preparing eprosartin
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
IL126184A0 (en) Process for preparing pentafluoropentanol
GB9703957D0 (en) Tempering system
GB9723540D0 (en) Support means
AU2421301A (en) Material transfer system
GB2330510B (en) Plant support
IL133288A (en) Process for preparing 3-isochromanone
GB9706469D0 (en) Genetic method
IL125646A0 (en) Process for preparing n-pyruvyl-l-proline
IL121130A0 (en) Vertical adjusting support system
LT98059A (en) Process for preparing cationic flockulant
GB9909259D0 (en) Material transfer system
GB9700474D0 (en) Support system for horses
GB9709668D0 (en) Safety support for plants
GB9805373D0 (en) Central heating system
TW369803U (en) Modified water-wal temperature system for greenhouses